Logo
Home
Company ProfileBoards & StaffsMemberships & PartnersAcademy of JournalismCareersBlog(EN)Contact Us
Our JournalsInstruction for AuthorsBrieflands PoliciesPublish My ResearchJournal Management SystemArticle Processing ChargesOpen Peer ReviewPublishing Services
Publish My Book
  1. Brieflands
  2. journals
  3. Hepatitis Monthly
  4. Articles

  5. Efficacy of PEGylated Interferon in Treatment-Experienced Chinese Patients With HBeAg Positive Chronic Hepatitis B
  6. Scopus by Title (Ref)

Hepatitis Monthly

Official Journal of Research Center for Gastroenterology and Liver Diseases

Home
Current IssueAccepted ManuscriptsAll IssuesIn Press ArticlesSearch
Instructions
Journal InformationBoards and committeesIndexing and Listing SourcesJournal MetricsOpen Peer Review (OPR)Publication Ethics and Malpractice StatementReviewer and AE Registration FormSupportContact Us
APC
Authors GuideSubmit Manuscript

Scopus by Title (Ref)


1. Sustained serological and complete responses in HBeAg-positive patients treated with Peginterferon alfa-2b: A 6-year long-term follow-up of a multicenter, randomized, controlled trial in China

- Sun J. , et al.

2. Comparison of hepatitis B virus core-related antigen and hepatitis B surface antigen for predicting HBeAg seroconversion in chronic hepatitis B patients with pegylated interferon therapy

- Wang M.L. , et al.

3. Switching to PegIFNα-2b leads to HBsAg loss in patients with low HBsAg levels and HBV DNA suppressed by NAs

- Huang J. , et al.

HomeInstructionsAPC

Articles

  • Current Issue
  • Accepted Manuscripts
  • All Issues
  • In Press Articles
  • Search

About Journal

  • Journal Information
  • Boards and committees
  • Indexing and Listing Sources
  • Journal Metrics
  • Open Peer Review (OPR)
  • Publication Ethics and Malpractice Statement
  • Reviewer and AE Registration Form
  • Support
  • Contact Us
Support
Submit a Ticket
BrieflandsBrieflands

Science, Technical, Medical Publisher, Since 2007

All rights reserved by Brieflands, 2026.

Powered by Neoscriber.